Does Rallies show 13F holders for OPK?

Yes. Rallies tracks hedge fund and 13F ownership data for OPK, including fund names, share counts, latest tracked quarter, and position changes when available.

Is OPK research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OPK. It does not provide personalized investment advice.

OPK (Opko Health Inc.) Stock Analysis - Hedge Fund Holdings

Opko Health Inc. (OPK) is a publicly traded Healthcare sector company. As of May 21, 2026, OPK trades at $1.24 with a market cap of $853.25M and a P/E ratio of -4.50. OPK moved +7.83% today. Year to date, OPK is -3.91%; over the trailing twelve months it is -7.52%. Its 52-week range spans $0.98 to $2.04. Analyst consensus is strong buy with an average price target of $3.00. Rallies surfaces OPK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns OPK stock?

Hedge funds tracked by Rallies that own OPK include Sculptor Capital. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Opko Health Inc..

OPK Key Metrics

Key financial metrics for OPK
Metric	Value
Price	$1.24
Market Cap	$853.25M
P/E Ratio	-4.50
EPS	$-0.27
Dividend Yield	0.00%
52-Week High	$2.04
52-Week Low	$0.98
Volume	12
Avg Volume	0
Revenue (TTM)	$581.12M
Net Income	$-212.91M
Gross Margin	35.98%

Top Hedge Funds Holding OPK

Sculptor Capital holds 12.72M shares of OPK, changed +0.00% as of Mar 31, 2025.

Latest OPK News

ModeX to Reveal MDX3001 In Vivo CAR-T Generation and Deep B-Cell Depletion Data — May 12, 2026
OPKO Health Takes 15% Equity Stake in Nicoya for China RAYALDEE Expansion — Apr 30, 2026
OPKO Health Q1 Loss Improves to $54.8M; Diagnostics Breakeven by Mid-Year — Apr 29, 2026
OPKO Health Launches Phase 1 Trial for MDX2301 COVID-19 Antibody in 80 Adults — Apr 8, 2026
OPKO Health Beats Q4 Estimates with $148.5M Revenue, Guides $125M–$140M Q1 — Feb 27, 2026

Recent OPK Insider Trades

PAGANELLI JOHN A bought 10.00K (~$11.35K) on Mar 20, 2026.
FROST PHILLIP MD ET AL bought 102.37K (~$133.08K) on Nov 21, 2025.
FROST PHILLIP MD ET AL bought 3.89K (~$5.14K) on Nov 21, 2025.

OPK Analyst Consensus

4 analysts cover OPK: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.00.

Common questions about OPK

Who owns OPK stock?: Hedge funds tracked by Rallies that own OPK include Sculptor Capital. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Opko Health Inc..
Does Rallies show 13F holders for OPK?: Yes. Rallies tracks hedge fund and 13F ownership data for OPK, including fund names, share counts, latest tracked quarter, and position changes when available.
Is OPK research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OPK. It does not provide personalized investment advice.